BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7592664)

  • 1. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
    Puri RN; Kumar A; Chen H; Colman RF; Colman RW
    J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of platelet responses by 2-[3-(bromo-2-oxopropylthio)]adenosine-5'-diphosphate involves its binding to as well as covalent modification of an ADP-receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Arch Biochem Biophys; 1997 Jul; 343(1):140-5. PubMed ID: 9210656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoaffinity method to identify aggregin, a putative ADP-receptor in human blood platelets.
    Puri RN; Colman RW
    Arch Biochem Biophys; 1997 Nov; 347(2):263-70. PubMed ID: 9367534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor.
    Puri RN; Colman RW
    Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
    Puri RN; Colman RW
    J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity labeling of the allosteric ADP activation site of NAD-dependent isocitrate dehydrogenase by 6-(4-bromo-2,3-dioxobutyl)thioadenosine 5'-diphosphate.
    Huang YC; Colman RF
    J Biol Chem; 1984 Oct; 259(20):12481-8. PubMed ID: 6548473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
    Puri RN; Colman RW
    Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregin: a platelet ADP receptor that mediates activation.
    Colman RW
    FASEB J; 1990 Mar; 4(5):1425-35. PubMed ID: 2407587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of NAD-dependent isocitrate dehydrogenase by affinity labeling of the allosteric ADP site by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate.
    Huang YC; Bailey JM; Colman RF
    J Biol Chem; 1986 Oct; 261(30):14100-7. PubMed ID: 3771526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
    Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
    Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
    Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
    Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaction of pyruvate kinase with the new nucleotide affinity labels 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 5'-diphosphate and 5'-triphosphate.
    DeCamp DL; Lim S; Colman RF
    Biochemistry; 1988 Oct; 27(20):7651-8. PubMed ID: 3207694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartyl peptide labeled by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate in the allosteric ADP site of pig heart NAD+-dependent isocitrate dehydrogenase.
    Huang YC; Colman RF
    J Biol Chem; 1989 Jul; 264(21):12208-14. PubMed ID: 2745437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
    Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
    J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
    Soslau G; McKenzie RJ; Brodsky I; Devlin TM
    Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of platelet fibrinogen receptors by zinc ions: role of protein kinase C.
    Trybulec M; Kowalska MA; McLane MA; Silver L; Lu W; Niewiarowski S
    Proc Soc Exp Biol Med; 1993 May; 203(1):108-16. PubMed ID: 8475131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.